Impact of tumor microenvironment on oncolytic viral therapy

This publication has 69 references indexed in Scilit:

• Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
  Molecular Therapy, 2010
• Pharmacologic and Chemical Adjuvants in Tumor Virotherapy
  Chemical Reviews, 2009
• Hypoxia Enhances the Replication of Oncolytic Herpes Simplex Virus
  Molecular Therapy, 2009
• Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
  Molecular Therapy, 2009
• Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
  Proceedings of the National Academy of Sciences, 2008
• Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61
  Molecular Therapy, 2008
• Trichostatin A and Oncolytic HSV Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects
  Molecular Therapy, 2008
• Efficacy and Safety of the Oncolytic Herpes Simplex Virus rRp450 Alone and Combined With Cyclophosphamide
  Molecular Therapy, 2008
• Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo
  Molecular Therapy, 2008
• Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
  Proceedings of the National Academy of Sciences, 2006